Skip to Content

Canine Bone Cancer: The Big Story on Osteosarcoma In Dogs

Canine Bone Cancer: The Big Story on Osteosarcoma in dogs: Developed by Orvis.

Osteosarcoma is an aggressive cancerous tumor that develops in the bone cells of a dog and rapidly spreads throughout the body resulting in death.

There is currently no cure for this type of bone cancer.

Most common breeds affected by osteosarcoma

While any breed can get bone cancer the breeds that are often diagnosed with osteosarcoma are Boxers, Doberman Pinschers, Golden Retrievers, German Shepherd Dogs, Great Danes, Great Pyrenees, Greyhounds, Irish Setters, Irish Wolfhounds, Labrador Retrievers, Newfoundlands, Rottweilers, Saint Bernards, and Weimaraners.

Osteosarcoma By The Numbers:

  • 10,000 dogs diagnosed with osteosarcoma each year.
  • Osteosarcoma occurs 10x more frequently in dogs than humans.
  • 20% to 50% greater risk for male dogs.
  • Accounts for roughly 5% of all canine tumors and 85% of all canine bone tumors.
  • 80% of dogs die within two years of diagnosis and in 90% of cases, cancer has already spread upon diagnosis.
  • 4,000 – 8,000 dogs die annually from metastatic disease.

Osteosarcoma is linked to rapid growth and it is more common in large and giant breed dogs.

To counteract this trend, large and giant breed puppy food has reduced levels of available energy, designed to slow the time needed for large breed puppies to reach their maximum size.

Two of the most common causes that can be linked to osteosarcoma in dogs are rapid growth and blunt bone injury

Believed to be fundamentally a genetic disease, there is currently no definitive connection between family members, yet osteosarcoma is certainly more prevalent in some breeds.

  • 75% – 85% of osteosarcoma cases occur in the limbs.
  • 15% of all Scottish Deerhounds die from osteosarcoma.
  • Dogs over 80 lbs. are 60 times more likely to develop osteosarcoma than dogs weighing less than 75 lbs.
  • Two of the most common causes that can be linked to osteosarcoma in dogs are rapid growth and blunt bone injury.

Diagnosis of Bone Cancer in Dogs

The most common symptoms of osteosarcoma in dogs include swelling, visible lameness, joint and bone pain, and even bone fractures caused by the weakening of bones due to the osteosarcoma growth. If you notice your dog limping or in pain, you should immediately contact your vet.

Using an X-Ray, MRI, or CT scan to identify the location of a tumor, a surgeon will then perform a biopsy on the tumor to collect cells to determine if it is indeed osteosarcoma.

Treatment and Prognosis of Osteosarcoma in Dogs

“Leg of Life”

Currently, the most effective standard of care, if the tumor occurs in a limb, is to amputate to prevent the spread of the cancerous cells. When combined with adjuvant chemotherapy survival rates can be improved.

The most common symptoms of osteosarcoma in dogs include swelling, visible lameness, joint and bone pain, and even bone fractures caused by the weakening of bones due to the osteosarcoma growth

CHEMOTHERAPY IS ONLY EFFECTIVE WHEN THE PRIMARY TUMOR IS REMOVED.

  • 1 Year: 50% of dogs treated with the current standard of care survive at least 1 year (or 10% of a lifetime).
  • 2 Years: 20% of dogs with appendicular osteosarcoma who have the limb removed and undergo chemotherapy treatment, survive more than two years.
  • 5 – 6 years: Some dogs can live 5 or more years after the standard treatment.

The Future Of Treatment of Osteosarcoma in dogs

  • $5 Million for 5 Years of Research Morris Animal Foundation has committed $5 million in new research, funding the next five years in the battle against osteosarcoma in dogs.
  • Rapamycin A bacterium-derived drug that has traditionally been used to prevent rejection in organ transplants. It works by preventing the activation of T cells and B Cells. A previous study found that Rapamycin showed promise in the treatment of osteosarcoma in dogs. Two offshoot clinical trials are currently underway to study the effectiveness of Rapamycin in post-surgery treatment of metastatic disease.
  • Human Clues Recent studies have shown that the fibroblast growth factor signaling pathway is abnormally activated in a variety of human tumors. MORRIS ANIMAL FOUNDATION researchers are investigating the role of this pathway in bone cancer spread and its potential as a new therapeutic target. TAILORING TREATMENT TO INDIVIDUALS – cancer gene signatures have been shown to be good predictors of how a tumor will respond to a specific chemotherapy drug.

HOW YOU CAN HELP

With the continued support of Morris Animal Foundation by Orvis and people like you, answers to treatment and survival of osteosarcoma in dogs are within reach.

Visit morrisanimalfoundation.org for more information about the fight against osteosarcoma and Morris Foundation’s many other projects.

You can help in the fight against canine cancer through the Orvis Cover Dog Contest. Visit orvis.com/coverdog to get started.

REFERENCES

All information sourced from the Morris Animal Foundation.

Sharing is caring!

We All Make Mistakes
← Previous
15 Reasons Why Newfie Moms Rock
Next →

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This site uses Akismet to reduce spam. Learn how your comment data is processed.